RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

About US: SciLucent provides US-based regulatory, scientific, technical consulting and authoring services to companies that develop pharmaceuticals, biopharmaceuticals, medical devices, and combination products.  Since 1998 we have provided our clients with innovative strategies and exceptional quality work products aimed at the US FDA and intended to enhance product development, approval, and marketing presence. Our services are geared towards three distinct client needs, which can be broadly identified as Program Strategy, Study Planning and Execution, and Technical Authoring (IND, NDA, BLA, etc.) and Regulatory support.
Web Site: https://scilucent.com/

585 Grove Street
Suite 300
Herndon, VA 20170
United States


Andrew Verderame, MBA, RAC
Phone: 1-203-415-7721
Email: a.verderame@scilucent.com

Business Type:
  • Consulting Services
  • CMC (Manufacturing and Development)
  • Quality and Compliance
  • Non-Clinical Safety and Development
  • Clinical Development
  • Audits
  • Regulatory Affairs Strategy
  • FDA Agent
  • Regulatory Operations